In vitro detection and quantification of botulinum neurotoxin type E activity in avian blood

Applied and Environmental Microbiology

Volumn 77, Issue 21, 2011, Pages 7815-7822

  Piazza, Timothy M ^a,b   Blehert, David S ^c   Dunning, F Mark ^b   Berlowski Zier, Brenda M ^c   Zeytin, Füsûn N ^b   Samuel, Michael D ^c   Tucker, Ward C ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b BioSentinel Pharmaceuticals Inc   (United States)

^c NATIONAL WILDLIFE HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY DETECTION; BLOOD SAMPLES; BOTULINUM NEUROTOXINS; DETECTION LIMITS; FEMTOMOLAR QUANTITIES; GREAT LAKES; IMMUNOPRECIPITATIONS; IN-VITRO; IN-VITRO ASSAYS; MATRIX; RESONANCE ENERGY TRANSFER; SEROTYPES;

ENERGY TRANSFER; LAKES; MAMMALS;

BLOOD;

BOTULINUM TOXIN; BOTULINUM TOXIN E;

AVIFAUNA; BIOASSAY; BLOOD; DETECTION METHOD; ENZYME ACTIVITY; ESTIMATION METHOD; INCUBATION; MORTALITY; PROTEIN; SENSITIVITY ANALYSIS; TOXIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD; BIRD DISEASE; BLOOD; BLOOD ANALYSIS; BOTULISM; CHEMICAL ANALYSIS; EVALUATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOPRECIPITATION; METHODOLOGY; SENSITIVITY AND SPECIFICITY; TIME; UNITED STATES;

ANIMALS; BIRD DISEASES; BIRDS; BLOOD CHEMICAL ANALYSIS; BOTULINUM TOXINS; BOTULISM; CHEMISTRY TECHNIQUES, ANALYTICAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREAT LAKES REGION; IMMUNOPRECIPITATION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

GREAT LAKES [NORTH AMERICA];

EID: 83155161704     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.06165-11     Document Type: Article

References (47)

1. Allison, S. 2004. Fluid, electrolytes and nutrition. Clin. Med. 4:573-578.
2. AOAC International. 2001. AOAC official method 977.26 (sec. 17.7.01). Clostridium botulinum and its toxins in foods. In Official methods of analysis, 17th ed. AOAC International, Gaithersburg, MD.
3. Austin, J. W., and D. Leclair. 2011. Botulism in the north: a disease without borders. Clin. Infect. Dis. 52:593-594.
4. Baldwin, M. R., et al. 2005. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E. Infect. Immun. 73:6998-7005.
5. Barr, J. R., et al. 2005. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg. Infect. Dis. 11:1578-1583.
6. Blasi, J., et al. 1993. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163.
7. Blasi, J., et al. 1993. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12:4821-4828.
8. Bott, T. L., J. S. Deffner, E. McCoy, and E. M. Foster. 1966. Clostridium botulinum type E in fish from the Great Lakes. J. Bacteriol. 91:919-924.
9. Boyer, A. E., et al. 2005. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal. Chem. 77:3916-3924.
10. Cai, S., B. R. Singh, and S. Sharma. 2007. Botulism diagnostics: from clinical symptoms to in vitro assays. Crit. Rev. Microbiol. 33:109-125.
11. Chen, S., and J. T. Barbieri. 2007. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J. Biol. Chem. 282:25540-25547.
12. Chen, S., and J. T. Barbieri. 2006. Unique substrate recognition by botulinum neurotoxins serotypes A and E. J. Biol. Chem. 281:10906-10911.
13. Dong, M., W. H. Tepp, E. A. Johnson, and E. R. Chapman. 2004. Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc. Natl. Acad. Sci. U. S. A. 101:14701-14706.
14. Galvin, J. W., T. J. Hollier, K. D. Bodinnar, and C. M. Bunn. 1985. An outbreak of botulism in wild waterbirds in southern Australia. J. Wildl. Dis. 21:347-350.
15. Gaunt, P. S., S. R. Kalb, and J. R. Barr. 2007. Detection of botulinum type E toxin in channel catfish with visceral toxicosis syndrome using catfish bioassay and Endopep mass spectrometry. J. Vet. Diagn. Invest. 19:349-354.
16. Getchell, R. G., et al. 2006. Quantitative polymerase chain reaction assay used to measure the prevalence of Clostridium botulinum type E in fish in the lower great lakes. J. Aquat. Anim. Health 18:39-50.
17. Gilmore, M. A., et al. 2011. Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity. Anal. Biochem. 413:36-42.
18. Gupta, D., and C. Lis. 2010. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr. J. 9:69.
19. Hannett, G. E., W. B. Stone, S. W. Davis, and D. Wroblewski. 2011. Biodiversity of Clostridium botulinum type E associated with a large outbreak of botulism in wildlife from Lake Erie and Lake Ontario. Appl. Environ. Microbiol. 77:1061-1068.
20. Hines, H. B., et al. 2008. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E. Appl. Environ. Microbiol. 74:653-659.
21. Hoque, M. A., L. F. Skerratt, M. A. Rahman, A. B. Beg, and N. C. Debnath. 2010. Factors limiting traditional household duck production in Bangladesh. Trop. Anim. Health Prod. 42:1579-1587.
22. Horowitz, B. Z. 2005. Botulinum toxin. Crit. Care Clin. 21:825-839.
23. Kalb, S. R., et al. 2006. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal. Biochem. 351:84-92.
24. Kumaran, D., R. Rawat, S. A. Ahmed, and S. Swaminathan. 2008. Substrate binding mode and its implication on drug design for botulinum neurotoxin A. PLoS Pathog. 4:e1000165.
25. Lafrancois, B. M., S. C. Riley, D. S. Blehert, and A. E. Ballmann. 2011. Links between type E botulism outbreaks, lake levels, and surface water temperatures in Lake Michigan, 1963-2008. J. Great Lakes Res. 37:86-91.
26. Leclair, D., F. Pagotto, J. M. Farber, B. Cadieux, and J. W. Austin. 2006. Comparison of DNA fingerprinting methods for use in investigation of type E botulism outbreaks in the Canadian Arctic. J. Clin. Microbiol. 44:1635-1644.
27. Lindstrom, M., and H. Korkeala. 2006. Laboratory diagnostics of botulism. Clin. Microbiol. Rev. 19:298-314.
28. Loutfy, M. R., J. W. Austin, B. Blanchfield, and I. W. Fong. 2003. An outbreak of foodborne botulism in Ontario. Can. J. Infect. Dis. 14:206-209.
29. Neimanis, A., et al. 2007. An outbreak of type C botulism in herring gulls (Larus argentatus) in southeastern Sweden. J. Wildl. Dis. 43:327-336.
30. Nol, P., J. L. Williamson, T. E. Rocke, and T. M. Yuill. 2004. Detection of Clostridium botulinum type C cells in the gastrointestinal tracts of Mozambique tilapia (Oreochromis mossambicus) by polymerase chain reaction. J. Wildl. Dis. 40:749-753.
31. Peck, M. W., and K. P. Robert. 2009. Biology and genomic analysis of Clostridium botulinum. Adv. Microb. Physiol. 55:183-265, 320.
32. Pérez-Fuentetaja, A., M. D. Clapsadl, D. Einhouse, P. R. G. R. G. Bowser, and W. T. Lee. 2006. Influence of limnological conditions on Clostridium botulinum type E presence in eastern Lake Erie sediments (Great Lakes, USA). Hydrobiologia 563:189-200.
33. Pérez-Fuentetaja, A., et al. 2011. Clostridium botulinum type E in Lake Erie: interannual differences and role of benthic invertebrates. J. Great Lakes Res. 37:238-244.
34. Rocke, T. E., and M. Friend. 1999. Avian botulism. United States Geological Survey information and technology report 1999-2001. U.S. Geological Survey, Reston, VA.
35. Ross, J. A., et al. 2011. Characterization of Forster resonance energy transfer in a botulinum neurotoxin protease assay. Anal. Biochem. 413:43-49.
36. Rossetto, O., et al. 1994. SNARE motif and neurotoxins. Nature 372:415-416.
37. Ruge, D. R., et al. 2011. Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters. Anal. Biochem. 411:200-209.
38. Schantz, E. J., and D. A. Kautter. 1978. Microbiological methods: standardized assay for Clostridium botulinum toxins. J. AOAC 61:96-99.
39. Schiavo, G., O. Rossetto, F. Benfenati, B. Poulain, and C. Montecucco. 1994. Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann. N. Y. Acad. Sci. 710:65-75.
40. Schiavo, G., et al. 1993. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem. 268:23784-23787.
41. Schiavo, G., C. C. Shone, O. Rossetto, F. C. Alexander, and C. Montecucco. 1993. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268:11516-11519.
42. Sesardic, D., T. Leung, and R. Gaines Das. 2003. Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin. Biologicals 31:265-276.
43. Shapiro, R. L., C. Hatheway, and D. L. Swerdlow. 1998. Botulism in the United States: a clinical and epidemiologic review. Ann. Intern. Med. 129: 221-228.
44. Sobel, J. 2005. Botulism. Clin. Infect. Dis. 41:1167-1173.
45. Woo, G. H., et al. 2010. Outbreak of botulism (Clostridium botulinum type C) in wild waterfowl: Seoul, Korea. J. Wildl. Dis. 46:951-955.
46. Work, T. M., J. L. Klavitter, M. H. Reynolds, and D. Blehert. 2010. Avian botulism: a case study in translocated endangered Laysan ducks (Anas laysanensis) on Midway Atoll. J. Wildl. Dis. 46:499-506.
47. Yule, A. M., J. W. Austin, I. K. Barker, B. Cadieux, and R. D. Moccia. 2006. Persistence of Clostridium botulinum neurotoxin type E in tissues from selected freshwater fish species: implications to public health. J. Food Prot. 69:1164-1167.